Health
Simple blood test diagnoses Parkinson's disease long before symptoms appear — A new research report appearing in the December issue of the FASEB Journal (http://www.fasebj.org) shows how scientists from the United Kingdom have developed a simple blood test to…
Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Where am I? > Home > News > Health

Mice with human body's defences

Science Centric | 6 October 2010 06:20 GMT
Printable version A clip for your blog or website E-mail the story to a friend
Bookmark or share the story on your social network Vote for this article Decrease text size Increase text size
DON'T MISS —
Can Nintendo Wii game consoles improve family fitness?
Can Nintendo Wii game consoles improve family fitness? — Consumer research suggests the Nintendo Wii Fit video game console was among this year's most popular Christmas gifts, but…
Patient-derived induced stem cells retain disease traits
Patient-derived induced stem cells retain disease traits — When neurones started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased. The dying cells - the same…
More Health

Therapeutic antibodies can be an efficient alternative when common drugs do not work anymore. However, antibodies obtained from blood of animals such as mice could not be used: The human immune system recognises them as foreign and rejects them. In an international cooperation, scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany have now succeeded in developing a promising approach to solve this problem; with the help of human stem cells they generated mice with a human immune system, which were then vaccinated to produce human monoclonal antibodies. These fully human antibodies could help in the research and therapy of human diseases. Their results have now been published in the current online issue of the scientific journal 'PLoS One.'

Antibodies are small proteins, produced by B cells during an immune response. They bind at and thus mark invading pathogens so that scavenger cells recognise and destroy them. 'The task of our immune system is to distinguish between self and non-self structures,' says Professor Carlos A. Guzman, head of the department of 'Vaccinology and Applied Microbiology' at the HZI. 'This means also that only human antibodies come into question for an antibody therapy,' since the human immune system fights antibodies from mice - a threat for the patient. Furthermore, it is cumbersome to humanise murine antibodies for human treatment or to generate human B cell clones producing high quantities of antibodies.

The scientists used an already established method to give a human immune system to mice, which were then exploited to solve this problem: they injected human stem cells into young mice that due to a genetic defect lack an immune system. The stem cells migrate into the bone marrow, proliferate, differentiate and lead to the generation of a human immune system. 'In our in-depth investigations we were able to detect all important types of immune cells in these mice,' says Dr Pablo Becker, scientist in the HZI department 'Vaccinology and Applied Microbiology.'

To validate the new approach, mice with a human immune system were vaccinated against Hepatitis B or Tetanus. The scientists then isolated human antibody producing B cells from the mice and treated them so that they survive outside the body in a cell culture dish and continue producing antibodies. Then, the researchers took a deeper look at the antibodies. The results give hope: 'Antibodies from mice with a human immune system showed good properties in our tests, but the model still needs to be improved for broad implementation in biomedicine,' says Pablo Becker. 'However, we were able to demonstrate for the first time that it is possible to produce human monoclonal antibodies using humanised mice.' Now it is important to improve this mouse model to use it one day for the development of advanced therapies against human diseases. 'In the future this approach might represent the most powerful tool to develop therapeutic antibodies for clinical use,' hopes Becker.

Source: Helmholtz Association of German Research Centres


Leave a comment
The details you provide on this page [e-mail address] will not be used to send unsolicited e-mail, and will not be supplied to a third party! Please note that we can not promise to give everyone a response. Comments are fully moderated. Once approved they will be posted within 24 hours.
Expand the form to leave a comment

RSS FEEDS, NEWSLETTER
Find the topic you want. Science Centric offers several RSS feeds for the News section.

Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.

How the brain thinks about crime and punishmentHow the brain thinks about crime and punishment

— In a pioneering, interdisciplinary study combining law and neuroscience, researchers at Vanderbilt University peered inside people's minds to watch how the brain…

Loving the addictLoving the addict

— There's been a fair bit of study on people who are addicted, but what about the people who love and care for the addicted? What's it like for them? That's what occurred…

Professor publishes 'Folktales of the Amazon'Professor publishes 'Folktales of the Amazon'

— As a boy living on a small farm with his grandparents in the Amazon region of Colombia, Juan Carlos Galeano was entranced with the lush, naturalistic and often violent…

Scientists probe limits of 'cancer stem-cell model'Scientists probe limits of 'cancer stem-cell model'

— One of the most promising new ideas about the causes of cancer, known as the cancer stem-cell model, must be reassessed because it is based largely on evidence from…

Popular tags in Health: cancer · diabetes · malaria · obesity